Neurologic Disorders News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Gene research offers hope for those with brain disorders - MSR News Online



MSR News Online
 
Gene research offers hope for those with brain disorders 
MSR News Online
Research scientists have come to a better understanding of many brain (neurologic) conditions and diseases that were common, yet poorly understood. These disorders include the likes of depression, autism, bipolar disorder, schizophrenia and alcoholism ...

and more » 


Related Epidemics? Teen Mental Health Crisis & Neurodevelopmental Disorders - The Epoch Times



The Epoch Times
 
Related Epidemics? Teen Mental Health Crisis & Neurodevelopmental Disorders 
The Epoch Times
The CDC tells us that ?mental disorders among children are an important public health issue because of their prevalence, early onset, and impact on the child, family, and community.? When an adolescent is too incapacitated by a mental or neurological ...

 


Cancer Immunotherapy: Kinder but Not Harmless - Medscape



Medscape
 
Cancer Immunotherapy: Kinder but Not Harmless 
Medscape
Knowledge of the long-term impact of cancer immunotherapies on the body is still incomplete. Nevertheless, immunotherapy is increasingly becoming the standard of care for many types of cancer?melanoma, non?small cell lung cancer, and bladder cancer ...

and more » 


Symptoms in neurologic disease reversed in model - Science Daily



Symptoms in neurologic disease reversed in model 
Science Daily
It is a parent's nightmare: a child is born apparently healthy, then stops meeting developmental milestones at one year old. Her verbal and motor skills vanish, and irregular breathing, seizures, and a host of other problems appear. The cause is Rett ...

and more » 


Partner Therapeutics (PTx) Announces the Appointment of Colleen Mockbee as Chief Development Officer - Markets Insider



Markets Insider
 
Partner Therapeutics (PTx) Announces the Appointment of Colleen Mockbee as Chief Development Officer 
Markets Insider
"I believe our first program, Leukine, has great potential, as a differentiated immune-stimulant, to positively impact the lives of many more patients as we pursue a breadth of development opportunities including combinations with immuno-oncology, the ...

 


Meet the Team at Mischer Neuroscience Center at Memorial Hermann The Woodlands Medical Center - Woodlands Online



Meet the Team at Mischer Neuroscience Center at Memorial Hermann The Woodlands Medical Center 
Woodlands Online
Led by UTHealth neurosurgeon Geoffrey Zubay, MD, a multidisciplinary team of neurosurgeons, neurologists, experienced critical care nurses, nurse practitioners and other specialized medical support personnel diagnose and treat a variety of neurological ...

 


Canbiola, Inc. (CANB) Announces the Addition of Dr. Maciej Matt Ferenc to its Medical Advisory Board - GlobeNewswire (press release)



Canbiola, Inc. (CANB) Announces the Addition of Dr. Maciej Matt Ferenc to its Medical Advisory Board 
GlobeNewswire (press release)
Canbiola's CBD products are at the forefront of emerging treatment protocols in a wide range of disease states including chronic pain, neurologic disorders, psychiatric disabilities and potential cancer treatments. The research and dedication of ...

and more » 


Adamas Pharmaceuticals (ADMS) Announces Quarterly Earnings Results, Misses Expectations By $0.09 EPS - The Ledger Gazette



The Ledger Gazette
 
Adamas Pharmaceuticals (ADMS) Announces Quarterly Earnings Results, Misses Expectations By $0.09 EPS 
The Ledger Gazette
Adamas Pharmaceuticals logo Adamas Pharmaceuticals (NASDAQ:ADMS) announced its quarterly earnings data on Thursday. The specialty pharmaceutical company reported ($1.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.18 ...
Adamas Pharmaceuticals (NASDAQ:ADMS) Given Daily Media Impact Score of 0.10 Dispatch Tribunal
Adamas Pharmaceuticals (ADMS) Issues Earnings Results The Lincolnian Online
Adamas Pharmaceuticals (ADMS) Posts Earnings Results, Misses Estimates By $0.09 EPS Enterprise Leader
Zacks 
all 31 news articles » 


Low-Dose vs Standard-Dose tPA for Neurologic Recovery in Acute Ischemic Stroke - Neurology Advisor



Neurology Advisor
 
Low-Dose vs Standard-Dose tPA for Neurologic Recovery in Acute Ischemic Stroke 
Neurology Advisor
Low-dose tPA and standard-dose tPA were associated with similar improvements in outcome (odds ratio [OR] = .92, 95% CI: 0.84-1.02; P =.12) and functional independence (OR = .97, 95% CI: 0.88-1.08; P =.57). Low-dose tPA was associated with a ...

 


Availability of Decadron Tablets Announced - Monthly Prescribing Reference



Availability of Decadron Tablets Announced 
Monthly Prescribing Reference
Decadron (dexamethasone) tablets are expected to be available sometime in early 2018, according to a press release from Pragma Pharmaceuticals. Decadron is a first-generation adrenocortical steroid primarily used for its anti-inflammatory effects in ...